TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.
Open a New Account, or Login if you're a client.
Yesterday
- Show headlines and story abstract
, from 4:35PM ET on Tuesday Dec 10, 2024 by Dow Jones Arcus Biosciences Announces New Employment Inducement Grants
4:35PM ET on Tuesday Dec 10, 2024 by Dow Jones
Dec 3, 2024
- Show headlines and story abstract
, from 4:35PM ET on Tuesday Dec 03, 2024 by Dow Jones Arcus Biosciences Announces New Employment Inducement Grants
4:35PM ET on Tuesday Dec 03, 2024 by Dow Jones
Nov 19, 2024
- Show headlines and story abstract
, from 4:05PM ET on Tuesday Nov 19, 2024 by Dow Jones Arcus Biosciences to Participate in Two Upcoming Investor Conferences
4:05PM ET on Tuesday Nov 19, 2024 by Dow Jones
Nov 12, 2024
- Show headlines and story abstract
, from 4:35PM ET on Tuesday Nov 12, 2024 by Dow Jones Arcus Biosciences Announces New Employment Inducement Grants
4:35PM ET on Tuesday Nov 12, 2024 by Dow Jones
Peers Headlines
Today
, from 3 hours ago by Accesswire SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVN
3 hours ago by Accesswire, from 3 hours ago by Dow Jones SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVN
3 hours ago by Dow Jones, from 10 hours ago by Dow Jones DJ Arvinas Price Target Maintained With a $87.00/Share by HC Wainwright & Co.
10 hours ago by Dow Jones, from 10 hours ago by Dow Jones DJ Nurix Therapeutics Is Maintained at Buy by HC Wainwright & Co.
10 hours ago by Dow Jones
Yesterday
, from 1:08PM ET on Tuesday Dec 10, 2024 by Dow Jones DJ Nurix Therapeutics Initiated at Buy by BTIG
1:08PM ET on Tuesday Dec 10, 2024 by Dow Jones, from 10:05AM ET on Tuesday Dec 10, 2024 by MT Newswires Arvinas, Pfizer Present 'Encouraging' Preliminary Data for Prospective Breast Cancer Treatment
10:05AM ET on Tuesday Dec 10, 2024 by MT Newswires, from 9:05AM ET on Tuesday Dec 10, 2024 by Dow Jones Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub-Study of Vepdegestrant in Combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium
9:05AM ET on Tuesday Dec 10, 2024 by Dow Jones, from 6:12AM ET on Tuesday Dec 10, 2024 by Dow Jones DJ Nurix Therapeutics Price Target Maintained With a $29.00/Share by Needham
6:12AM ET on Tuesday Dec 10, 2024 by Dow Jones
Dec 9, 2024
, from 6:00PM ET on Monday Dec 09, 2024 by Dow Jones Nurix Therapeutics Presents New Positive Data from Phase 1a/1b Clinical Trial of NX-5948 in Chronic Lymphocytic Leukemia at the 66th American Society of Hematology Annual Meeting
6:00PM ET on Monday Dec 09, 2024 by Dow Jones
Dec 6, 2024
, from 8:36AM ET on Friday Dec 06, 2024 by MT Newswires BMO Capital Initiates Nurix Therapeutics at Outperform With $35 Price Target
8:36AM ET on Friday Dec 06, 2024 by MT Newswires